---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-241906"
form_type: "8-K"
ticker: "XOMA"
cik: "0000791908"
company_name: "XOMA Royalty Corp"
filed_at: "2021-08-10T23:59:59+00:00"
generated_at: "2026-06-29T17:35:05.575101+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# XOMA adds Blaze Bioscience CEO Heather Franklin to board; board expands to 8

## Summary
- Heather Franklin elected to board effective Aug 6, 2021; board increases from 7 to 8.
- Granted initial option for 13,136 shares vesting monthly over 3 years.
- Also granted pro-rated option for 4,146 shares vesting through May 2022 or 2022 annual meeting.
- Franklin will receive standard non-employee director cash compensation per existing policy.
- No related-party transactions or arrangements with any person in connection with appointment.

## SEC filing metadata
- accession: 0001193125-21-241906
- form_type: 8-K
- ticker: XOMA
- cik: 0000791908
- company_name: XOMA Royalty Corp
- filed_at: 2021-08-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/791908/000119312521241906/0001193125-21-241906-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/791908/000119312521241906/d180939d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-241906
- JSON: https://secwatch.observer/filing/0001193125-21-241906.json
- Plain text: https://secwatch.observer/filing/0001193125-21-241906.txt

## Key facts
- Executive change
  Heather Franklin was elected as Director at XOMA Royalty Corp.
  - Action: elected
  - Role: Director
  source text: On August 6, 2021, the Board of Directors (the “Board”) of XOMA Corporation (the “Company” or “XOMA”) increased the size of the Board from seven to eight directors and, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, elected Heather Franklin, Chief Executive Officer of Blaze Bioscience, Inc. to the Board, effective August 6, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/791908/000119312521241906/0001193125-21-241906-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.